11-13 June 2019
Postillion Hotel Amsterdam,
Amsterdam, NL
Bringing you the latest science, technologies and partners needed to accelerate next generation antibodies towards commercial success
Early Confirmed Keynote Presenters for 2019!
Join This List of Alumni from 2018
AB Studio Inc
Ablynx
Ablynx NV
Adaptimmune Ltd
Aduro Biotech Europe
Aelian Biotechnology
AIMM Therapeutics
Amgen Research Munich GmbH
Amgen, Inc.
Antikor Biopharma Ltd
Aptevo Therapeutics
Argen-X N.V.
BioNTech
Boehringer Ingelheim
Boehringer Ingelheim Pharmaceutical Inc.
Celyad S.A.
CEPC, INSTITUT DE RECHERCHE PIERRE FABRE
Christian-Albrechts-University Kiel
ChromoTek GmbH
CHRU Besancon/ITAC platform
CRUK-MEDIMMUNE
CureVac AG
Elasmogen Ltd
EPO Berlin-Buch GmbH (EPO)
ErasmusMC
ESPCI
ETH Zurich
ETH Zurich/Swiss Federal Institute of Te
Experimental Biotherapeutics Centre
FairJourney Biologics
Garvan Institute of Medical Research
Genentech, Inc.
Genmab BV
Ghent University
Gilead Sciences
Ginkgo Bioworks
Goshen College
Gustave Roussy Cancer Centre
Institute of Molecular & Cell Biology
Iontas
Kagoshima University
Karolinska Institutet
Kookmin University
Kyowa Hakko
Kirin
LakePharma
Leiden University
Leiden University Medical Center
LifeArc
MedImmune
Nestle Skin Health
Nestle Skin Health/Galderma RandD
Novimmune SA
peptron
Prothix B.V.
Radboud Institute for Molecular Life Sci
Ragon Institute of MGH, MIT and Harvard
Roche Innovation Center Zurich
Sanofi
Sanofi Aventis R & D
Shemyakin and Ovchinnikov Institute of B
Specifica
Symphogen AS
Tagworks Pharmaceuticals
Taipei Medical University
Takis Srl
The Harley Street Clinic
The Netherlands Cancer Institute
TheraPharm Deutschland GmbH
Tohoku University
TU-Braunschweig, Dep. Biotechnology
UCB UCb Celltech
UCL Cancer Institute
UMC
Utrecht University College London
University Hospital of Erlangen
University Medical Center Hamburg-Eppend
University of Cologne
University of Oxford
University of Southampton
University of Zurich
Uppsala University
Utrecht University
WuXi Biologics
Y-mAbs Therapeutics, Inc.
YUMAB GmbH
Zymeworks Inc
By the Numbers
250+
50+
30+
Submit a Poster at Antibody Engineering & Therapeutics
Share your company's new research by presenting a poster at Antibody Engineering & Therapeutics Europe. Posters should be in PORTRAIT orientation and no larger than 1m wide x 1.5m high.
Please note that all poster presenters must be registered attendees.
More information regarding posters will be forthcoming.
Call for Speaker is Now Open!
If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:
- New Antibody Formats and Effector Functions
- Antibody Therapeutics for Autoimmune and Neurodegenerative Diseases
- Turning Antibody Leads into Drugs
- T Cell Engineering with Antibodies
- Bioinformatics and Repertoires in Antibody Discovery and Development
- Clinical Developments in Antibody Therapeutics
- Bispecific Antibodies: New Strategies and Case Studies
- Antibody-drug Conjugates (ADCs): New Strategies and Case Studies
Deadline to submit a proposal is 21 December 2018
Become an Event Sponsor or Exhibitor
Showcase your products and services to antibody scientists and executives. To request a floor plan, or to see a list of available package options, please contact Aimee Croke at aimee.croke@knect365.com or +1-857-504-6697 or Kristin Skahan at kristin.skahan@knect365.com or +1-857-504-6730.
About The Antibody Society
The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field.
We are:
- Creating opportunities for education and networking;
- Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
- Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
- Engaging government and international agencies on matters concerning the antibody community;
Please join us!
